Stocks in news: Angel One, Maruti Suzuki, Dabur, Marico, Aurobindo Pharma, ITC
Equity markets traded flat on Tuesday, taking a pause after Monday's decline. In today's trade, shares of Maruti Suzuki
, Marico
, Aurobindo Pharma
, Angel One
among others will be in focus due to second quarter updates and various news developments.
Maruti SuzukiMaruti Suzuki reported a nearly 2% jump in September total sales at 1,84,727 units versus 1,81,343 units in the corresponding month of the previous financial year.
DaburThe FMCG major is expected to post a mid-single digit decline in consolidated revenue for the quarter ended September 2024 amid correction in its India operations.
Dr Reddy's
Dr Reddy's signed a voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countries.
Read more: Here's the trade setup for today's session
Zydus LifeZydus Life received tentative approval from USFDA for Enzalutamide Tablets, which are used for the treatment of patients with castration-resistant prostate cancer.
Ashoka BuildconAshoka Buildcon received 2 letters of awards worth Rs 1,264 crore from MMRDA for design and construction of two creek bridges.
Eicher MotorsEicher Motors
posted Royal Enfield sales growth of 11% to 86.978 units, while exports were up 77% at 7,652 units during the September month.
arm ITC Infotech India acquired 100% shares of Blazeclan Technologies for about Rs 485 crore.
Ujjivan Small Finance BankThe Reserve Bank of India granted an authorised dealer category 1 licence to the bank.
Aurobindo PharmaHyderabad-headquartered Aurobindo Pharma received final approval from the US FDA to manufacture and market Cephalexin Tablets USP in both 250 milligram (mg) and 500 mg dosages.
JSW CementJSW Cement added 2 MTPA capacity at its Vijayanagar Plant, Karnataka. With this addition, JSW Cement’s total capacity increases to 20.6 MTPA.
MaricoMarico said there has been a sequential improvement in volume growth with the domestic business reporting mid-single-digit volume growth during the quarter ended September 2024.
Angel OneShares of broker Angel One will be in focus after the market regulator Sebi announced a series of steps to curb derivatives trading, which have an impact on the volumes in the segment.
(You can now subscribe to our ETMarkets WhatsApp channel)
, Marico
, Aurobindo Pharma
, Angel One
among others will be in focus due to second quarter updates and various news developments.
Maruti SuzukiMaruti Suzuki reported a nearly 2% jump in September total sales at 1,84,727 units versus 1,81,343 units in the corresponding month of the previous financial year.
DaburThe FMCG major is expected to post a mid-single digit decline in consolidated revenue for the quarter ended September 2024 amid correction in its India operations.
Dr Reddy's
Dr Reddy's signed a voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countries.
Read more: Here's the trade setup for today's session
Zydus LifeZydus Life received tentative approval from USFDA for Enzalutamide Tablets, which are used for the treatment of patients with castration-resistant prostate cancer.
Ashoka BuildconAshoka Buildcon received 2 letters of awards worth Rs 1,264 crore from MMRDA for design and construction of two creek bridges.
Eicher MotorsEicher Motors
posted Royal Enfield sales growth of 11% to 86.978 units, while exports were up 77% at 7,652 units during the September month.
arm ITC Infotech India acquired 100% shares of Blazeclan Technologies for about Rs 485 crore.
Ujjivan Small Finance BankThe Reserve Bank of India granted an authorised dealer category 1 licence to the bank.
Aurobindo PharmaHyderabad-headquartered Aurobindo Pharma received final approval from the US FDA to manufacture and market Cephalexin Tablets USP in both 250 milligram (mg) and 500 mg dosages.
JSW CementJSW Cement added 2 MTPA capacity at its Vijayanagar Plant, Karnataka. With this addition, JSW Cement’s total capacity increases to 20.6 MTPA.
MaricoMarico said there has been a sequential improvement in volume growth with the domestic business reporting mid-single-digit volume growth during the quarter ended September 2024.
Angel OneShares of broker Angel One will be in focus after the market regulator Sebi announced a series of steps to curb derivatives trading, which have an impact on the volumes in the segment.
(You can now subscribe to our ETMarkets WhatsApp channel)